Methamphetamine-induced neurotoxicity: the road to Parkinson's disease (Q28270691)

Europe PubMed Central

title

Methamphetamine-induced neurotoxicity: the road to Parkinson's disease (English)

0 references

1 reference

1 reference

1 reference

Bessy Thrash

1

0 references

Kariharan Thiruchelvan

2

0 references

Manuj Ahuja

3

0 references

Vishnu Suppiramaniam

4

0 references

Muralikrishnan Dhanasekaran

5

0 references

language of work or name

English

0 references

publication date

2009

1 reference

Group I mGluR antagonist AIDA protects nigral DA cells from MPTP-induced injury

PubMed

published in

Pharmacological Reports

0 references

volume

61

0 references

issue

6

0 references

page(s)

966-77

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Involvement of free radicals in MPP+ neurotoxicity against rat dopaminergic neurons in culture

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Methamphetamine-induced neurotoxicity in mouse brain is attenuated by ketoprofen, a non-steroidal anti-inflammatory drug

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Glutamate and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Amantadine inhibits NMDA receptors by accelerating channel closure during channel block.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Exposure of mice to tobacco smoke attenuates the toxic effect of methamphetamine on dopamine systems

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Paraquat: model for oxidant-initiated toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

The non-competitive NMDA-receptor antagonist MK-801 prevents the massive release of glutamate and aspartate from rat striatum induced by 1-methyl-4-phenylpyridinium (MPP+).

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Glutamate neurotoxicity and diseases of the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Amantadine treatment of fatigue associated with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Molecular Pathways of Neurodegeneration in Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Environmental factors in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Tamoxifen diminishes methamphetamine-induced striatal dopamine depletion in intact female and male mice

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

The role of excitotoxicity in neurodegenerative disease: implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Non-cholinergic strategies for treating and preventing Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Microgliosis and down-regulation of adenosine transporter induced by methamphetamine in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

The oxidant stress hypothesis in Parkinson's disease: evidence supporting it

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Regional distribution of ubiquinones and tocopherols in the mouse brain: lowest content of ubiquinols in the substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Effect of acute and chronic methamphetamine treatment on tyrosine hydroxylase activity in brain and adrenal medulla.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Dose-dependent protective effects of apomorphine against methamphetamine-induced nigrostriatal damage

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Neuroprotective effects of the dopamine D2/D3 agonist pramipexole against postischemic or methamphetamine-induced degeneration of nigrostriatal neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Antioxidative Protection by Melatonin: Multiplicity of Mechanisms from Radical Detoxification to Radical Avoidance

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Protective effects of N-acetyl-L-cysteine on the reduction of dopamine transporters in the striatum of monkeys treated with methamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Delta opioid peptide [D-Ala2, D-Leu5]enkephalin causes a near complete blockade of the neuronal damage caused by a single high dose of methamphetamine: examining the role of p53.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Methamphetamine-induced serotonin neurotoxicity is attenuated in p53-knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Methamphetamine-induced dopaminergic neurotoxicity: role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Methamphetamine-induced dopaminergic neurotoxicity in mice: long-lasting sensitization to the locomotor stimulation and desensitization to the rewarding effects of methamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Oxidative stress in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

New insights into the cause of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Mechanisms of toxicity, clinical features, and management of diquat poisoning: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Comparison of the protective effect of melatonin with other antioxidants in the hamster kidney model of estradiol-induced DNA damage.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Hydroxyl radical scavenging activity of nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Serotonin reuptake inhibitor-induced sexual dysfunction and its treatment: a large-scale retrospective study of 596 psychiatric outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

1 reference

7 January 2021

Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Parkinson's disease: past, present, and future

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Early environmental origins of neurodegenerative disease in later life

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

The competitive NMDA antagonist CPP protects substantia nigra neurons from MPTP-induced degeneration in primates

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Methamphetamine-induced oxidative stress in cultured mouse astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Neuroprotective agents in traumatic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

1 reference

7 January 2021

Amantadine: an alternative for prevention of influenza

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Panel Urges Wide Use of Antiviral Drug

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

The nature, time course and severity of methamphetamine withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Melatonin protects against neuronal damage induced by 3-nitropropionic acid in rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Antiparkinsonian actions of ifenprodil in the MPTP-lesioned marmoset model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Effects of long-term administration of melatonin and a putative antagonist on the ageing rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Ramelteon: profile of a new sleep-promoting medication

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Status of antioxidant defense system and expression of toxicant responsive genes in striatum of maneb- and paraquat-induced Parkinson's disease phenotype in mouse: mechanism of neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Melatonin-A Highly Potent Endogenous Radical Scavenger and Electron Donor: New Aspects of the Oxidation Chemistry of this Indole Accessed in vitroa

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Free radical production induced by methamphetamine in rat striatal synaptosomes

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Free Radical-Mediated Molecular Damage

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Diagnosis and treatment of Parkinson disease: molecules to medicine

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Excitatory aminoacid antagonists provide a therapeutic approach to neurological disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

U-95666E: a potential anti-parkinsonian drug with anxiolytic activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Amantadine in the treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Therapeutic role of coenzyme Q(10) in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Update on Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and methamphetamine in several strains of mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Treatment of mice with methamphetamine produces cell loss in the substantia nigra.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Cytotoxic and genotoxic potential of dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Significance of melatonin in antioxidative defense system: reactions and products

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

The protective role of melatonin in experimental hypoxic brain damage.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

The mechanism of action of aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

The GABA(A) receptor mediates the hypnotic activity of melatonin in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Striatal dopamine nerve terminal markers in human, chronic methamphetamine users

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021

Selective inhibition of cyclooxygenase-2 exacerbates methamphetamine-induced dopamine depletion in the striatum in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970158-6

7 January 2021